Flagship Biotech International Private Limited — Levamisole Exporter Profile
Indian Pharmaceutical Exporter · #8 for Levamisole · $75.0K export value · DGFT Verified
Flagship Biotech International Private Limited is the #8 Indian exporter of Levamisole with $75.0K in export value and 10 verified shipments. Flagship Biotech International Private Limited holds a 2.8% market share in Levamisole exports across 2 countries. The company exports 4 pharmaceutical products worth $429.3K across 4 therapeutic categories.
Flagship Biotech International Private Limited — Levamisole Export Profile: Buyers & Destinations
Where Does Flagship Biotech International Private Limited Export Levamisole?
| Country | Value | Shipments | Share |
|---|---|---|---|
| AZARBAIJAN | $55.9K | 8 | 74.5% |
| UZBEKISTAN | $19.1K | 2 | 25.5% |
Flagship Biotech International Private Limited exports Levamisole to 2 countries. The largest destination is AZARBAIJAN accounting for 74.5% of Flagship Biotech International Private Limited's Levamisole shipments. These destinations reflect Flagship Biotech International Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Levamisole from Flagship Biotech International Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER | AZARBAIJAN | $61.7K | 7 |
| AZUNIVET LLC | AZARBAIJAN | $13.4K | 3 |
Flagship Biotech International Private Limited supplies Levamisole to 2 buyers globally. The largest buyer is TO THE ORDER (AZARBAIJAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Levamisole Export Value and How Much Does Flagship Biotech International Private Limited Contribute?
India exported $1.9M worth of Levamisole through 325 shipments from 72 suppliers to 39 countries, serving 104 buyers globally. Flagship Biotech International Private Limited contributes $75.0K to this total, accounting for 2.8% of India's Levamisole exports. Flagship Biotech International Private Limited ships Levamisole to 2 countries through 2 buyers.
What Is the Average Shipment Value for Flagship Biotech International Private Limited's Levamisole Exports?
Flagship Biotech International Private Limited's average Levamisole shipment value is $7.5K per consignment, based on 10 shipments totaling $75.0K. The largest destination is AZARBAIJAN (74.5% of Flagship Biotech International Private Limited's Levamisole exports).
How Does Flagship Biotech International Private Limited Compare to Other Indian Levamisole Exporters?
Flagship Biotech International Private Limited ranks #8 among 72 Indian Levamisole exporters with a 2.8% market share. The top 3 exporters are LYKA BDR INTERNATIONAL LIMITED ($550.0K), COMBITIC GLOBAL CAPLET PRIVATE LIMITED ($367.2K), DOSCH PHARMACEUTICALS PRIVATE LIMITED ($184.9K). Flagship Biotech International Private Limited processed 10 shipments to 2 destination countries.
What Levamisole Formulations Does Flagship Biotech International Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICAL FINISHED FORMULATION LEVAKSONID (OXYCLOZANIDE & LEVAMISOLE HYDROCHLORIDE ORAL SUSPENSION ) 1X1 LTR,U/R,UZNOS | $19.1K | 2 |
| PHARMACEUTICAL FINISHED FORMULATION HELMIPLUS (Levamisole 150mg,Oxfendazole 375mg and Oxyclonazide 750mg Tablets),1 x 10 | $17.1K | 1 |
| PHARMACEUTICAL FINISHED FORMULATION HELMIPLUS (LEVAMISOLE HYDROCLORIDE 150MG,OXFENDAZOLE 375MG AND OXYCLONAZIDE 750MG TANOS | $12.9K | 1 |
| PHARMACEUTICAL FINISHED FORMULATION ZANIMIKS (LEVAMISOLE HYDROCHLORIDE 3%& OXYCLOZANIDE 6% ORAL SUSPENSION),,1 X 1000 ML | $11.3K | 2 |
| PHARMACEUTICAL FINISHED FORMULATION ZANIMIKS (LEVAMISOLE HYDROCHLORIDE 3%& OXYCLOZANIDE 6% ORAL SUSPENSION),1 X 500 ML,ENOS | $8.4K | 2 |
| PHARMACEUTICAL FINISHED FORMULATION ZANIMIKS (Levamisole Hydrochloride 3%& Oxyclozanide 6% Oral Suspension),,1 x 1000 ml | $4.1K | 1 |
| PHARMACEUTICAL FINISHED FORMULATION, ZANIMIKS (LEVAMISOLE HYDROCHLORIDE 3%& OXYCLOZANIDE 6% ORAL SUSPENSION),1 X 500 ML, | $2.1K | 1 |
Flagship Biotech International Private Limited exports 7 distinct Levamisole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMACEUTICAL FINISHED FORMULATION LEVAKSONID (OXYCLOZANIDE with 2 shipments worth $19.1K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Flagship Biotech International Private Limited Compare to Nearest Levamisole Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | DIPS BIOSCIENCE PRIVATE LIMITED | $95.5K | 4 | 1 | $23.9K |
| 7 | ASHISH LIFE SCIENCE PRIVATE LIMITED | $93.6K | 9 | 5 | $10.4K |
| 8 | FLAGSHIP BIOTECH INTERNATIONAL PRIVATE LIMITED ★ | $75.0K | 10 | 2 | $7.5K |
| 9 | AMBADNYA LIFE SCIENCE LLP | $58.8K | 4 | 1 | $14.7K |
| 10 | SHREE PHARMA INDIA | $50.2K | 8 | 1 | $6.3K |
Flagship Biotech International Private Limited ranks #8 among 72 Indian Levamisole exporters. Average shipment value of $7.5K compared to the market average of $26.4K. The closest competitors by value are DIPS BIOSCIENCE PRIVATE LIMITED and ASHISH LIFE SCIENCE PRIVATE LIMITED.
Which Indian Ports Ship Levamisole Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 59 | 18.2% |
| NHAVA SHEVA SEA (INNSA1) | 54 | 16.6% |
| SAHAR AIR CARGO ACC (INBOM4) | 37 | 11.4% |
| JNPT/ NHAVA SHEVA SEA | 21 | 6.5% |
| JNPT | 19 | 5.8% |
| NHAVA SHEVA | 16 | 4.9% |
| SONEPAT ICD | 13 | 4.0% |
| Bombay Air | 11 | 3.4% |
About Flagship Biotech International Private Limited
Flagship Biotech International Private Limited exports 4 products worth $429.3K. Beyond Levamisole, top products include Teicoplanin, Antitoxin, Tamoxifen. View the complete Flagship Biotech International Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Levamisole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Levamisole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Flagship Biotech International Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 10 individual customs records matching Flagship Biotech International Private Limited exporting Levamisole, covering 7 formulations to 2 countries via 2 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 39+ countries, 104+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Levamisole Export Data from Flagship Biotech International Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Flagship Biotech International Private Limited's Levamisole exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Flagship Biotech International Private Limited
Full Company Profile →
4 products · $429.3K total trade · 4 categories
Levamisole Stats
Company Overview
Top Products by Flagship Biotech International Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Flagship Biotech International Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Levamisole. For current shipment-level data, contact TransData Nexus.